Universitätsklinikum Frankfurt am Main (KGU)

MicroRNA miR-29b regulates diabetic aortic remodeling and stiffening. (2021) Schellinger IN, Wagenhaeuser M, Chodisetti G, Mattern K, Dannert A, Petzold A, Jakubizka-Smorag J, et al. Journal article Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis. (2021) Tietz AK, Angstwurm K, Baumgartner T, Doppler K, Eisenhut K, Elisak M, Franke A, et al. Journal article Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer (2021) Schneeweiss A, Michel LL, Möbus V, Tesch H, Klare P, Hahnen E, Denkert C, et al. Journal article Erratum: AGO Recommendations for the Surgical Therapy of the Axilla after Neoadjuvant Chemotherapy: 2021 Update (Geburtshilfe Frauenheilkd (2021) 81:10 (1112-1120) DOI: 10.1055/a-1499-8431) (2021) Friedrich M, Kühn T, Janni W, Müller V, Banys-Paluchowski M, Kolberg-Liedtke C, Jackisch C, et al. Journal article, Erratum Entwicklung von Qualitätsstandards für die Versorgung von Patient*innen mit rheumatoider Arthritis zur Anwendung in Deutschland (2021) Kiltz U, Buschhorn-Milberger , Albrecht K, Lakomek HJ, Lorenz HM, Rudwaleit M, Schneider M, et al. Journal article Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial (2021) Llop-Guevara A, Loibl S, Villacampa G, Vladimirova V, Schneeweiss A, Karn T, Zahm DM, et al. Journal article Phase III post-neoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA (2021) Marme F, Hanusch C, Furlanetto J, Denkert C, Link T, Untch M, Blohmer JU, et al. Conference contribution Behandlung der Psoriasis mit Secukinumab: Praxisrelevante Hinweise (2021) Körber A, Augustin M, Behrens F, Gerdes S, von Kiedrowski R, Schäkel K, Sticherling M, et al. Journal article, Review article Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa) (2021) Eichler M, Pink D, Menge F, Jakob J, Hentschel L, Richter S, Hohenberger P, et al. Journal article S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics (2021) Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Gunther C, Iking-Konert C, et al. Journal article